FDA Center for Drug Evaluation & Research Issues Warning Letter to Bausch & Lomb
September 16, 2026
September 16, 2026
WASHINGTON, Sept. 16 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Bausch and Lomb Inc. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Robert T. Fulop, Director of Site Operations, Bausch & Lomb Inc., 8500 Hidden River Parkway, Tampa, FL 33637-1014, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARN . . .
* * *
Recipient: Mr. Robert T. Fulop, Director of Site Operations, Bausch & Lomb Inc., 8500 Hidden River Parkway, Tampa, FL 33637-1014, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARN . . .